IL1B and Alzheimer disease: In contrast, IL-1β showed an opposite trend in the cortex, which may be attributed to the dual role of IL-1β in AD: in the early stage of neuroinflammation, IL-1β can promote the activation of neuroprotective pathways, while in the late stage, it exacerbates neuronal damage [39].